(Q44895140)

English

Phosphatidylinositol-3 kinase inhibitors reproduce the selective antiproliferative effects of imatinib on chronic myeloid leukaemia progenitor cells

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Phosphatidylinositol-3 kinase inhibitors reproduce the selective antiproliferative effects of imatinib on chronic myeloid leukaemia progenitor cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

S B Marley

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

J L Lewis

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

H Schneider

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

C E Rudd

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

M Y Gordon

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

language of work or name

0 references

publication date

1 May 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

125

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

500-511

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Phosphoinositide kinases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Phosphoinositide 3-kinase and the regulation of cell growth

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Several Bcr-Abl kinase domain mutants associated with imatinib mesylate resistance remain sensitive to imatinib

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

GM-CSF can improve the cytogenetic response obtained with interferon-alpha therapy in patients with chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Abl kinase but not PI3-kinase links to the cytoskeletal defects in Bcr-Abl transformed cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Cell biology of CML cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Clinical heterogeneity in chronic myeloid leukaemia reflecting biological diversity in normal persons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Phosphatidylinositol-3 kinase inhibitors enhance the anti-leukemia effect of STI571.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Opposing effects of PI3 kinase pathway activation on human myeloid and erythroid progenitor cell proliferation and differentiation in vitro

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Progenitor cells from patients with advanced phase chronic myeloid leukaemia respond to STI571 in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Effects of combinations of therapeutic agents on the proliferation of progenitor cells in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

The survival function of the Bcr-Abl oncogene is mediated by Bad-dependent and -independent pathways: roles for phosphatidylinositol 3-kinase and Raf.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Signaling pathways activated by interferons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Dominant negative MYC blocks transformation by ABL oncogenes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Phosphoinositide 3-kinases and membrane traffic

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Signaling by distinct classes of phosphoinositide 3-kinases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

PI 3-kinase: a pivotal pathway in T-cell activation?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.04933.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2004.04933.X

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44895140&oldid=2055922187"